GLENVIEW CAPITAL MANAGEMENT, LLC Cytek Biosciences, Inc. Transaction History

GLENVIEW CAPITAL MANAGEMENT, LLC portfolio value:

$0
portfolio value

GLENVIEW CAPITAL MANAGEMENT, LLC quarter portfolio value change:

+37.19%
quarter

Cytek Biosciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -500K shares -5.36M $14.72 0
Q2 2022 share Increase +802.32% 444.58K shares 4.76M $10.73 500K
Q1 2022 share Increase 0.00% 55.41K shares 597K $10.78 55.41K